0QAH

Merck & (0QAH)

Merck & Co Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0QAH

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/29	22 : 22	Alliance News	Merck & Co enhances ophthalmology portfolio with EyeBio acquisition	LSE:0QAH	Merck & Co Inc
2024/04/25	20 : 13	Alliance News	Merck & Co raises annual outlook thanks to first quarter boost	LSE:0QAH	Merck & Co Inc
2024/03/16	00 : 23	Alliance News	IN BRIEF: Merck hails positive data on cervical cancer drug, Keytruda	LSE:0QAH	Merck & Co Inc
2024/02/21	06 : 15	Alliance News	Merck and Astellas drugs get priority review in US and Japan	LSE:0QAH	Merck & Co Inc
2024/02/01	21 : 57	Alliance News	TOP NEWS: Merck books 2023 growth despite gefapixant rejection hit	LSE:0QAH	Merck & Co Inc
2024/01/19	20 : 29	Alliance News	IN BRIEF: Arix Bioscience eyes USD19 million return from Harpoon sale	LSE:0QAH	Merck & Co Inc
2024/01/08	23 : 20	Alliance News	Merck to buy Harpoon Therapeutics for about USD680 million	LSE:0QAH	Merck & Co Inc
2023/12/18	20 : 04	Alliance News	Astellas, Merck, Pfizer celebrate US approval for Keytruda plus Padcev	LSE:0QAH	Merck & Co Inc
2023/12/15	17 : 41	Alliance News	Merck gets US FDA nod for Welireg, as trial with Moderna bears fruit	LSE:0QAH	Merck & Co Inc
2023/12/12	02 : 56	Alliance News	Merck reports mixed updates for cancer treatment, Keytruda	LSE:0QAH	Merck & Co Inc
2023/10/26	20 : 17	Alliance News	TOP NEWS: Merck hails Daiichi Sankyo partnership but will take charge	LSE:0QAH	Merck & Co Inc
2023/10/20	14 : 06	Alliance News	TOP NEWS: Daiichi Sankyo soars on USD22 billion Merck cancer drug deal	LSE:0QAH	Merck & Co Inc
2023/10/04	01 : 00	Alliance News	Drugmakers agree to US government price talks amid pushback	LSE:0QAH	Merck & Co Inc
2023/08/25	00 : 24	Alliance News	UPDATE: AstraZeneca, Merck & Co say Lynparza approved in Japan	LSE:0QAH	Merck & Co Inc
2023/08/01	20 : 49	Alliance News	Merck & Co second quarter revenue up; profit falls acquisition costs	LSE:0QAH	Merck & Co Inc
2023/06/16	21 : 09	Alliance News	Merck says latest trial data shows Keytruda meets survival endpoint	LSE:0QAH	Merck & Co Inc
2023/06/01	21 : 44	Alliance News	Merck and Astra's Lynparza prostate cancer treatment gets US approval	LSE:0QAH	Merck & Co Inc
2023/05/01	20 : 35	Alliance News	AstraZeneca "disappointed" with US ODAC's guidance on Lynparza	LSE:0QAH	Merck & Co Inc
2023/04/27	20 : 49	Alliance News	Merck & Co beats on first-quarter revenue and hails "advancements"	LSE:0QAH	Merck & Co Inc
2023/03/10	21 : 31	Alliance News	Merck's Keytruda combination sees positive results in cancer trial	LSE:0QAH	Merck & Co Inc
2023/03/03	02 : 20	Alliance News	US FDA to discuss AstraZeneca and Merck's Lynparza cancer drug combo	LSE:0QAH	Merck & Co Inc
2023/02/24	21 : 48	Alliance News	IN BRIEF: EU refuses marketing recommendation for Merck's Lagevrio	LSE:0QAH	Merck & Co Inc
2023/02/02	22 : 08	Alliance News	TOP NEWS: Merck & Co annual net profit up but drops in fourth-quarter	LSE:0QAH	Merck & Co Inc
2023/01/31	01 : 35	Alliance News	Daiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatment	LSE:0QAH	Merck & Co Inc
2022/12/21	18 : 16	Alliance News	AstraZeneca wins two new approvals in EU for cancer drugs	LSE:0QAH	Merck & Co Inc
2022/12/21	03 : 09	Alliance News	FDA accepts Astellas, Seagen and Merck's combo for priority review	LSE:0QAH	Merck & Co Inc
2022/12/15	17 : 37	Alliance News	AstraZeneca and Merck receive US FDA extension for Lynparza review	LSE:0QAH	Merck & Co Inc
2022/11/23	02 : 18	Alliance News	IN BRIEF: Merck's Keytruda sees positive topline results in trial	LSE:0QAH	Merck & Co Inc
2022/11/21	21 : 53	Alliance News	Merck buys biopharmaceutical firm Imago BioSciences for USD1.4 billion	LSE:0QAH	Merck & Co Inc
2022/10/27	22 : 29	Alliance News	TOP NEWS: Merck & Co 3rd-quarter sales up; profit slips as costs rise	LSE:0QAH	Merck & Co Inc